AZD4954

DRUG2 trials

Sponsors

AstraZeneca

Conditions

DyslipidemiaHealthy Participants

Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

RecruitingNCT06980428

AstraZenecaDyslipidemia, Healthy Participants

Start: 2025-05-27End: 2027-04-09Target: 136Updated: 2026-08-24

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults

CompletedNCT07513571

AstraZenecaHealthy Participants

Start: 2026-04-10End: 2026-07-08Updated: 2026-08-04